Sponsors (2)
The bill expands screening, outreach, clinician support, and genetic/referral resources to detect colorectal cancer earlier in younger and underserved populations, but it risks open-ended federal costs, uneven state access, administrative burdens, and potential downstream patient expenses.
People under 45 and other younger adults at elevated risk can get funded early-detection testing and referrals, increasing chances of earlier diagnosis and treatment.
Underserved populations (rural, American Indian/Alaska Native, Black communities) will receive targeted outreach and awareness resources, improving equitable access to screening and detection.
Clinicians and health professionals can receive education and decision-support tools so they better identify symptoms and genetic risks in younger patients, improving diagnostic accuracy.
Taxpayers face open-ended federal spending because grants and programs are authorized as "such sums as may be necessary," with no specified cap.
Some states and the young people they serve may be left without new programs because funding is distributed via competitive grants, producing uneven access across states.
Low-income patients and others could incur downstream diagnostic and treatment costs if grants cover testing/referral but insurance does not cover subsequent care.
Based on analysis of 3 sections of legislative text.
Authorizes CDC-run competitive grants to states to increase awareness, testing, referrals, clinician education, and navigation for colorectal cancer detection in people under 45.
Official title: Authorize the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to make grants to States to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer in young individuals, and for other purposes.
Introduced August 6, 2026 by Thomas Jonathan Ossoff · Last progress August 6, 2026
Authorizes competitive CDC grants to states, DC, and U.S. territories to increase awareness, education, and early detection of colorectal cancer in "young individuals" (under 45). Grants fund outreach, diagnostic testing for high-risk young people, referrals (including genetic counseling/testing), public awareness campaigns, clinician education, patient navigation, surveillance, and evaluation. States must apply with a plan targeting higher-risk young people (family history, IBD, inherited syndromes, symptoms, type 2 diabetes) and underserved populations (rural, American Indian/Alaska Native, African American), describe partnerships and activities, and report to HHS within five years. Authorization is for five-year grants (renewable) and allows "such sums as may be necessary."